Drug-Eluting Stents Versus Bare Metal Stents for Narrowing in Saphenous Vein Grafts

American Journal of Cardiology

Volumn 102, Issue 5, 2008, Pages 530-534

  Okabe, Teruo ^a   Lindsay, Joseph ^a   Buch, Ashesh N ^a   Steinberg, Daniel H ^a   Roy, Probal ^a   Slottow, Tina L Pinto ^a   Smith, Kimberly ^a   Torguson, Rebecca ^a   Xue, Zhenyi ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Pichard, Augusto D ^a   Weissman, Neil J ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; METAL; PACLITAXEL; RAPAMYCIN; TROPONIN I;

ADULT; AGED; ARTICLE; CORONARY ARTERY; CORONARY STENT; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GRAFT DYSFUNCTION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; Q WAVE; REVASCULARIZATION; SAPHENOUS VEIN GRAFT;

AGED; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CREATINE KINASE, MB FORM; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; METALS; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; SAPHENOUS VEIN; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 51749099574     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.04.041     Document Type: Article

References (20)

1. Stephan W.J., O'Keefe J.J.H., Piehler J.M., McCallister B.D., Dahiya R.S., Shumshak T., Ligfon R.W., and Hartzler G.O. Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery. J Am Coll Cardiol 28 (1996) 1140-1146
2. Morrison D.A., Sethi G., Sacks J., Henderson W.G., Grover F., Sedlis S., Esposito R., Investigators of the Department of Veterans Affairs Cooperative Study #385, and the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. J Am Coll Cardiol 40 (2002) 1951-1954
3. Keeley E.C., Velez C.A., O'Neil W.W., and Safian R.D. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous intervention on saphenous vein grafts. J Am Coll Cardiol 38 (2001) 659-665
4. de Jaegere P.P., van Domburg R.T., Feyter P.J., Ruygrok P.N., van der Giessen W.J., van den Brand M.J., and Serruys P.W. Long-term clinical outcome after stent implantation in saphenous vein grafts. J Am Coll Cardiol 28 (1996) 89-96
5. Chu W.W., Rha S.W., Kuchulakanti P.K., Cheneau E., Torguson R., Pinnow E., Alexieva-Fournadjiev J., Pichard A.D., Satler L.F., Kent K.M., Lindsay J., and Waksman R. Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention. Am J Cardiol 97 (2006) 34-37
6. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Hayashi E.B., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., Molnar F., Falotico R., and THE RAVEL STUDY group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
7. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz R.E., and SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
8. Schofer J., Schluter M., Gershlick A.H., Wijns W., Garcia E., Schampaert E., Breithardt G., and E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS). Lancet 362 (2003) 1093-1099
9. Colombo A., Drzewiecki J., Banning A., Grube E., Hauptmann K., Silber S., Dudek D., Fort S., Schiele F., Zmudka K., Guagliumi G., Russell M.E., and TAXUS II Study Group. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108 (2003) 788-794
10. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J.J., Russell M.E., and TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
11. Hong M.K., Mintz G.S., Lee C.W., Song J.M., Han K.H., Kang D.H., Song J.K., Kim J.J., Weissman N.J., Fearnot N.E., Park S.W., and Park S.J. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation 107 (2003) 517-520
12. Grube E., Silber S., Hauptmann K.E., Mueller R., Buellesfeld L., Gerckens U., and Russell M.E. TAXUS I six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 107 (2003) 38-42
13. Tsuchida K., Ong A.T.L., Aoki J., van Mieghem C.A.G., Rodriguez-Granillo G.A., Valgimigli M., Sianos G., Regar E., McFadden E.P., van Der Giessen W.J., et al. Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with paclitaxel-eluting stents. Am J Cardiol 96 (2005) 395-398
14. Vermeersch P., Agostoni P., Verheye S., van den Heurvel P., Convens C., Bruining N., van den Branden F., and van Langenhove G. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC trial. J Am Coll Cardiol 48 (2006) 2423-2431
15. Vermeersch P., Agostoni P., Verheye S., van den Heurvel P., Convens C., van den Branden F., van Langenhove G., and DELAYED RRISC (Death and Events at Long-term follow-up AnalYsis: Extended Duration of the Reduction of Restenosis In Saphenous vein grafts with Cypher stent) Investigators. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC trial. J Am Coll Cardiol 50 (2007) 261-267
16. Ge L., Iakovou I., Sangiorgi G.M., Chieffo A., Melzi G., Cosgrave J., Montorfano M., Michev I., Airoldi F., Carlino M., Corvaja N., and Colombo A. Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome. J Am Coll Cardiol 45 (2005) 989-994
17. Bhargava B., Kornowski R., Mehran R., Kent K.M., Hong M.K., Lansky A.J., Waksman R., Pichard A.D., Satler L.F., and Leon M.B. Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting. J Am Coll Cardiol 35 (2000) 389-397
18. Mishra S., Wolfram R.M., Torguson R., Chu W.W., Xue Z., Gevorkian N., Donekal S., Chan R., Pichard A.D., Satler L.F., Kent K.M., and Waksman R. Comparison of effectiveness and safety of drug-eluting stents versus vascular brachytherapy for saphenous vein graft in-stent restenosis. Am J Cardiol 97 (2006) 1303-1307
19. Hong M.K., Mehran R., Dangas G., Mints G.S., Lansky A.J., Pichard A.D., Kent K.M., Satler L.F., Stone G.W., and Leon M.B. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 100 (1999) 2400-2405
20. Tardiff B.E., Califf R.M., Tcheng J.E., Lincoff A.M., Sigmon K.N., Harrington R.A., Mahaffey K.W., Ohman E.M., Teirstein P.S., Blankenship J.C., Kitt M.M., Topol E.J., and IMPACT-II Investigators. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. J Am Coll Cardiol 33 (1999) 88-96